Meeting Abstract

Effectiveness of Different Dosages of Retreatment of Rituximab in Combination with Leflunomide: Results from a Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study


Authors listBehrens, Frank; Rossmanith, Tanja; Koehm, Michaela; Alten, Rieke; Aringer, Martin; Burmester, G. R.; Feist, Eugen; Krueger, Klaus; Mueller-Ladner, Ulf; Rubbert-Roth, Andrea; Wassenberg, Siegfried; Tony, Hans-Peter; Kellner, Herbert; Backhaus, Marina; Burkhardt, Harald

Publication year2016

JournalArthritis & Rheumatology

Volume number68

ISSN2326-5191

eISSN2326-5205

ConferenceAnnual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Health-Professionals (ACR/ARHP)

PublisherWiley



Citation Styles

Harvard Citation styleBehrens, F., Rossmanith, T., Koehm, M., Alten, R., Aringer, M., Burmester, G., et al. (2016) Effectiveness of Different Dosages of Retreatment of Rituximab in Combination with Leflunomide: Results from a Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study, Arthritis & Rheumatology, 68

APA Citation styleBehrens, F., Rossmanith, T., Koehm, M., Alten, R., Aringer, M., Burmester, G., Feist, E., Krueger, K., Mueller-Ladner, U., Rubbert-Roth, A., Wassenberg, S., Tony, H., Kellner, H., Backhaus, M., & Burkhardt, H. (2016). Effectiveness of Different Dosages of Retreatment of Rituximab in Combination with Leflunomide: Results from a Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study. Arthritis & Rheumatology. 68.


Last updated on 2025-02-04 at 01:44